Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT01136317
PHASE2
Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects
Sponsor: Nantes University Hospital
View on ClinicalTrials.gov
Summary
This study aims to determine, in obese subjects, the antisecretory effect of a single dose of placebo, rabeprazole 20 mg and omeprazole 20 mg using 24h gastric pH monitoring, in a prospective, monocentre, randomized manner. Monitorings are separated between 6 and10 days. The main outcome criteria of analysis is the percentage of time with gastric pH above 3 during 24hours.
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
Not specified
Start Date
2010-04
Completion Date
2010-07
Last Updated
2026-09-14
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Omeprazole
DRUG
Rabeprazole
DRUG
Lactose
Locations (1)
CHU de Nantes
Nantes, France